| Ensembl 2020 AD Yates, P Achuthan, W Akanni, J Allen, J Allen, J Alvarez-Jarreta, ... Nucleic acids research 48 (D1), D682-D688, 2020 | 1730 | 2020 |
| Ensembl 2021 KL Howe, P Achuthan, J Allen, J Allen, J Alvarez-Jarreta, MR Amode, ... Nucleic acids research 49 (D1), D884-D891, 2021 | 1453 | 2021 |
| Ensembl 2022 F Cunningham, JE Allen, J Allen, J Alvarez-Jarreta, MR Amode, ... Nucleic acids research 50 (D1), D988-D995, 2022 | 1322 | 2022 |
| Ensembl 2019 F Cunningham, P Achuthan, W Akanni, J Allen, MR Amode, IM Armean, ... Nucleic acids research 47 (D1), D745-D751, 2019 | 974 | 2019 |
| Ensembl variation resources SE Hunt, W McLaren, L Gil, A Thormann, H Schuilenburg, D Sheppard, ... Database 2018, bay119, 2018 | 502 | 2018 |
| Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms A Mazein, M Ostaszewski, I Kuperstein, S Watterson, N Le Novère, ... NPJ systems biology and applications 4 (1), 21, 2018 | 92 | 2018 |
| Digital clocks: simple Boolean models can quantitatively describe circadian systems OE Akman, S Watterson, A Parton, N Binns, AJ Millar, P Ghazal Journal of The Royal Society Interface 9 (74), 2365-2382, 2012 | 81 | 2012 |
| The COVID-19 Data Portal: accelerating SARS-CoV-2 and COVID-19 research through rapid open access data sharing PW Harrison, R Lopez, N Rahman, SG Allen, R Aslam, N Buso, ... Nucleic acids research 49 (W1), W619-W623, 2021 | 67 | 2021 |
| Computational modelling of atherosclerosis A Parton, V McGilligan, M O’Kane, FR Baldrick, S Watterson Briefings in bioinformatics 17 (4), 562-575, 2016 | 67 | 2016 |
| Annotating and prioritizing genomic variants using the Ensembl Variant Effect Predictor—A tutorial SE Hunt, B Moore, RM Amode, IM Armean, D Lemos, A Mushtaq, ... Human mutation 43 (8), 986-997, 2022 | 25 | 2022 |
| New models of atherosclerosis and multi-drug therapeutic interventions A Parton, V McGilligan, M Chemaly, M O’Kane, S Watterson Bioinformatics 35 (14), 2449-2457, 2019 | 24 | 2019 |
| Is systems pharmacology ready to impact upon therapy development? A study on the cholesterol biosynthesis pathway HE Benson, S Watterson, JL Sharman, CP Mpamhanga, A Parton, ... British journal of pharmacology 174 (23), 4362-4382, 2017 | 19 | 2017 |
| The use of liquid chromatography/thermospray mass spectrometry with on‐line ultraviolet diode array and radiochemical detection: Characterization of the putative metabolites of … W Speed, AH Parton, IJ Martin, MR Howard Biological mass spectrometry 23 (1), 1-5, 1994 | 17 | 1994 |
| The Ensembl COVID-19 resource: ongoing integration of public SARS-CoV-2 data NH De Silva, J Bhai, M Chakiachvili, B Contreras-Moreira, C Cummins, ... Nucleic Acids Research 50 (D1), D765-D770, 2022 | 9 | 2022 |
| Purification of the T-cell receptor ζ-chain: covalent modification by 4-(2-aminoethyl)-benzenesulfonyl fluoride B Sweeney, K Proudfoot, AH Parton, LM King, P Slocombe, MJ Perry Analytical biochemistry 245 (1), 107-109, 1997 | 9 | 1997 |
| Metabolism of the bisphosphonate ester U-91502 in rats. JG Slatter, KL Feenstra, MJ Hauer, DA Kloosterman, AH Parton, ... Drug metabolism and disposition 24 (1), 65-73, 1996 | 8 | 1996 |
| PEERY. PJ CUNNINGHAM | 3 | 1915 |
| Tace/Adam17 Substrates Associate with Acs (Ep-CAM, HB-EGF) and Follow-Up Mace (TNFR1 and TNFR2) M Chemaly, R McAllister, A Peace, AJ Bjourson, S Watterson, A Parton, ... Atherosclerosis plus 50, 40-49, 2022 | 1 | 2022 |
| Enhanced access to extensive phenotype and disease annotation of genes and genetic variation in Ensembl IM Armean, L Gil, D Lemos, A Parton, H Schuilenburg, A Thormann, ... European Journal of Human Genetics 27, 1721-1721, 2019 | 1 | 2019 |
| Atherosclerosis Plus M Chemaly, R McAllister, A Peace, AJ Bjourson, S Watterson, A Parton, ... | | 2022 |
